Iomazenil (123I)

Iomazenil (123I)

SCHEMBL17022271

CCOC(=O)c1ncn2c1CN(C)C(=O)c1c([123I])cccc1-2

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 13/20 0.71
GABRG2 P18507 12/20 0.71
GABRB3 P28472 12/20 0.71
GABRA5 P31644 12/20 0.71
GABRA3 P34903 12/20 0.71
GABRA2 P47869 12/20 0.71
GABRA6 Q16445 8/20 0.62
GABRB2 P47870 7/20 0.62
GABRA4 P48169 3/20 0.61
ALDH1A1 P00352 2/20 0.61
MEN1 O00255 1/20 0.61
GABRP O00591 1/20 0.61
GABRD O14764 1/20 0.61
CYP1A2 P05177 1/20 0.61
CYP2D6 P10635 1/20 0.61
TSHR P16473 1/20 0.61
GABRB1 P18505 1/20 0.61
CYP2C19 P33261 1/20 0.61
GABRE P78334 1/20 0.61
KMT2A Q03164 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iomazenil (123I) SCHEMBL29374678 1.00 GABRA1 (0.71) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL7334382 0.91 GABRA1 (0.75) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL10365966 0.89 GABRA1 (0.72) GABRA1GABRG2GABRB3GABRA5GABRA3
Iomazenil SCHEMBL29385986 0.88 GABRA1 (0.71) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL7329697 0.88 GABRA1 (0.71) GABRA1GABRG2GABRB3GABRA5GABRA3
Iomazenil SCHEMBL41658 0.88 GABRA1 (0.71) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL9745968 0.88 GABRA1 (0.71) GABRA1GABRG2GABRB3GABRA5GABRA3
Sarmazenil SCHEMBL195304 0.88 GABRA1 (0.71) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL10627713 0.87 GABRA1 (0.70) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL11887388 0.86 GABRA1 (0.68) GABRA1GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9550704-B2 Method for synthesizing radiopharmaceuticals using a cartridge FUTURECHEM CO., LTD. (KR) 2017-01-24 US disclosed
US-20150232392-A1 METHOD FOR SYNTHESIZING RADIOPHARMACEUTICALS USING A CARTRIDGE FUTURECHEM CO., LTD. (KR) 2015-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150232392-A1 METHOD FOR SYNTHESIZING RADIOPHARMACEUTICALS USING A CARTRIDGE ADCYAP1R1, PAICS, SSTR5 GABRA1 3166/4885GABRG2 3981/4885GABRB3 3467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.